SGLT2 Inhibitors Confer Cardiovascular Protection via the Gut-Kidney-Heart Axis: Mechanisms and Translational Perspectives

Yimei Tao, Ning Zhang, Zhaoxiang Wang, Ying Pan, Shao Zhong, Hongying Liu
ISSN / E-ISSN
— / —
DOI
10.3390/jcdd12120471 ↗
Volume · Issue · Pages
12 · 12 · 471-471
Publisher
MDPI AG
Article URL
https://doi.org/10.3390/jcdd12120471 ↗
Article details
Unverified
Publication date (each date has its type and source)
30 Nov 2025
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date30 Nov 2025 OpenAlex

Keywords (as given): SGLT2 inhibitors; gut dysbiosis; gut microbiota; short-chain fatty acids; trimethylamine; bile acid metabolism; intestinal barrier; tight junctions; systemic inflammation; cardiac remodeling; fecal microbiota transplantation; non-diabetic population

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Journal
Journal of Cardiovascular Development and Disease
Publication date used
30 Nov 2025 (OpenAlex publication date)
Applicable HEC period
2024–25 (version 1) · 01 Oct 2024 – 31 Mar 2026
Category
—
Recognition status
Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
Source
—
Verification status
Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.